Breast Cancer Trial, Recruiting NCT06545045 Sponsor: University of Missouri-Columbia Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06545045
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who report having memory or thinking problems since cancer treatment, rated as "Moderately," "Strongly," or "Extremely" on a self-report scale, and who score above 30 on a questionnaire about everyday mental mistakes
  • People who have finished active treatment for breast cancer (specifically invasive ductal or lobular breast cancer, Stages I, II, or III) at least 6 months ago but no more than 3 years ago
  • People who can read, write, and speak English fluently
  • People who are able to give informed consent to participate in the study
  • People who have a life expectancy of more than 6 months at the time of joining the trial
  • People who have been on a stable dose of any medications known to affect thinking or memory (such as antidepressants), with no changes in the past 90 days

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had cancer in another part of the body that has shown signs of being active in the past year
  • People who have a diagnosed brain or neurological condition that affects how the brain works or looks (for example, Parkinson's disease, dementia, or stroke), or who score below 23 on a standard memory and thinking assessment
  • People with severe depression symptoms, indicated by a score of 21 or higher on a standard depression questionnaire
  • People with a history of severe traumatic brain injury or a prolonged period of unconsciousness, such as a coma
  • People for whom an MRI scan would not be safe, for example due to electrical implants, medical pumps, or severe claustrophobia
  • People who have blue-yellow colour blindness
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna E Boone, PhD, OTR/L, University of Missouri Occupational Therapy

Phone: 5738827023

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Missouri-Columbia
Registry
ClinicalTrials.gov
Start date
31 October 2024
Est. completion
30 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility measures; Canadian Occupational Performance Measure (COPM) Performance; Canadian Occupational Performance Measure (COPM) Satisfaction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov